Ascentage Pharma Group International
HK$28.02-HK$0.20 (-0.71%)
Ascentage Pharma Group International’s quoted price sits in the lower half of its reported 52-week range, 59.6% below the high.
OTC · NWPN · USD
Stock price
Quote as of Jun 24, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
The Now Corporation’s quoted price sits in the lower half of its reported 52-week range, 87.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Currently in its development phase, The NOW Corporation functions as an entity focused on energy generation and production. Its diverse portfolio of activities includes the stewardship of a 250 KW wind turbine, the rehabilitation of indigenous stripper oil wells, and the end-to-end process of cultivating, gathering, and manufacturing hemp-based goods. The organization, which commenced operations in 1993, maintains its principal office in Portland, Oregon.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$28.02-HK$0.20 (-0.71%)
Ascentage Pharma Group International’s quoted price sits in the lower half of its reported 52-week range, 59.6% below the high.
A$8.85+A$0.30 (+3.51%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.79% below the high.
£2.04£0.00 (0.0%)
Diaceutics PLC’s quoted price sits in the upper half of its reported 52-week range, 3.1% below the high.
$0.12$0.00 (0.0%)
Creso Pharma Limited: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.43$0.00 (0.0%)
Cell MedX Corp.: Healthcare · Medical - Devices.
$37.00$0.00 (0.0%)
Leafly Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.78% below the high.
HK$0.90HK$0.00 (0.0%)
Tian An Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.19% below the high.
HK$1.06HK$0.00 (0.0%)
Lee's Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.72% below the high.